(Reuters) - The U.S. Federal Trade Commission said it filed a complaint in a district court accusing Endo International Plc of violating antitrust laws by striking "pay-for-delay" deals to block access to generic copies of its drugs.
http://ift.tt/xePdMM
from Reuters: Health News
via animenewspro
Aucun commentaire:
Enregistrer un commentaire